COMMUNIQUÉS West-GlobeNewswire

Amedisys Announces Fourth Quarter and Year End Earnings Release and Conference Call Date
06/02/2019
BATON ROUGE, La., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), announced today that it will report results for the fourth quarter and year ended December 31, 2018, after the market closes on February [...]
Sanofi: FDA approves Cablivi® (caplacizumab-yhdp), the first Nanobody®-based medicine, for adults with acquired thrombotic thrombocytopenic purpura (aTTP)
06/02/2019
FDA approves Cablivi ® (caplacizumab-yhdp), the first Nanobody ® -based medicine, for adults with acquired thrombotic thrombocytopenic purpura (aTTP) First medicine approved in the U.S. specifically for the treatment of [...]
Sanofi : La FDA approuve Cablivi® (caplacizumab-yhdp), le premier médicament à base de Nanobody® pour le traitement du purpura thrombotique thrombocytopénique (PTT) acquis de l'adulte
06/02/2019
La FDA approuve Cablivi ® (caplacizumab-yhdp), le premier médicament à base de Nanobody ® pour le traitement du purpura thrombotique thrombocytopénique (PTT) acquis de l'adulte Premier médicament spécifiquement approuvé [...]
Monthly information related to total number of voting rights and shares composing the share capital – January 31, 2019
06/02/2019
LYON, France, Feb. 06, 2019 (GLOBE NEWSWIRE) -- Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon - France Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: [...]
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social – 31 Janvier 2019
06/02/2019
LYON, France, 06 févr. 2019 (GLOBE NEWSWIRE) -- Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers Lyon - France Places de cotation : Euronext Paris de Euronext (Compartiment C - Code ISIN : [...]
The Centers for Medicare & Medicaid Services (CMS) Grants Alpha II Status as 2019 Qualified Registry
06/02/2019
Alpha II’s integrated, web-based registry service received status as a CMS qualified registry for sixth consecutive year TALLAHASSEE, Fla., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Alpha II, LLC , a leading developer of [...]
Tauriga Sciences Inc. Showcases its Graphic Design and Artwork for the Retail Display Box of its CBD Infused Gum
06/02/2019
New York, NY, Feb. 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG ) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and [...]
ImmuCell to Announce Financial Results for Fourth Quarter and Full Year 2018
06/02/2019
Conference Call Scheduled for Thursday, February 14, 2019 at 9:00 AM ET PORTLAND, Maine, Feb. 06, 2019 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health [...]
Sol-Gel Technologies Announces FDA Approval for Perrigo’s Generic Acyclovir Cream, 5%
06/02/2019
Sol-Gel and Perrigo will equally share the gross profits generated from sales of the product NESS ZIONA, Israel, Feb. 06, 2019 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (NASDAQ: SLGL) (Sol-Gel or the Company), a [...]
Cognoa Receives FDA Breakthrough Designations for Autism Diagnostic and Digital Therapeutic Devices
06/02/2019
Company announces first digital therapeutic device and precision health platform to support the developmental and behavioral health of children PALO ALTO, Calif., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Cognoa , a company at [...]
Cerner to Webcast Investment Community Meeting
06/02/2019
KANSAS CITY, Mo., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Cerner (Nasdaq: CERN) announced today that it will host its 2019 Investment Community Meeting on Feb. 13, 2019 and make the live meeting available through a webcast. [...]
Welldoc Submits 510(k) Filing to U.S. Food and Drug Administration to Expand its BlueStar® Digital Therapeutic to Help More Individuals Living with Diabetes
06/02/2019
Welldoc’s chronic disease portfolio grows with new features to support people with both type 1 and type 2 diabetes COLUMBIA, Md., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Welldoc , a leading digital health company, announced [...]
Editas Medicine Names David Scadden, M.D., to Board of Directors
06/02/2019
CAMBRIDGE, Mass., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ: EDIT), a leading genome editing company, today announced that it has appointed David T. Scadden, M.D., to its Board of Directors, [...]
Chemesis Advancing Domestically and Internationally, Plus Exclusive CEO Interview -- CFN Media
06/02/2019
SEATTLE, Feb. 06, 2019 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article and [...]
KLAS ranks Imprivata OneSign as 2019 Single Sign-On Category Leader
06/02/2019
Customers rate Imprivata in 2019 in Best in KLAS: Software & Services Report LEXINGTON, Mass., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Imprivata® , the healthcare IT security company, today announced that Imprivata [...]
Indiva Shapes Strong Brand Identity in Canada, Eyes Emerging European Market -- CFN Media
06/02/2019
SEATTLE, Feb. 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Marrone Bio Innovations’ almond bloom solutions increase farmer ROI and support new Almond Orchard 2025 Goals
06/02/2019
DAVIS, Calif., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. (NASDAQ: MBII) (MBI), a leading developer of biological crop protection and plant health solutions, is offering a pair of products – Haven ® [...]
FSD Pharma Looks to Grow Cannabinoids in Algae -- CFN Media
06/02/2019
SEATTLE, Feb. 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
resTORbio Appoints Erkan Baloglu, Ph.D., M.B.A., as Vice President of Drug Discovery and Medicinal Chemistry
06/02/2019
BOSTON, Feb. 06, 2019 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq:TORC), a clinical-stage biopharmaceutical company developing a new class of medicines that target the biology of aging to prevent or treat age-related [...]

Pages